205 related articles for article (PubMed ID: 31173814)
1. Natural history of histologically proven alcohol-related liver disease: A systematic review.
Parker R; Aithal GP; Becker U; Gleeson D; Masson S; Wyatt JI; Rowe IA;
J Hepatol; 2019 Sep; 71(3):586-593. PubMed ID: 31173814
[TBL] [Abstract][Full Text] [Related]
2. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study.
Deleuran T; Grønbaek H; Vilstrup H; Jepsen P
Aliment Pharmacol Ther; 2012 Jun; 35(11):1336-42. PubMed ID: 22490057
[TBL] [Abstract][Full Text] [Related]
3. Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis.
Spahr L; Rubbia-Brandt L; Genevay M; Hadengue A; Giostra E
BMC Gastroenterol; 2011 Oct; 11():115. PubMed ID: 22035247
[TBL] [Abstract][Full Text] [Related]
4. Presence of alcoholic steatohepatitis, but no selective histological feature, indicates an increased risk of cirrhosis and premature death.
Semb S; Neermark S; Dam-Larsen S; Franzmann MB; Albrectsen J; Kallemose T; Becker U; Bendtsen F
Scand J Gastroenterol; 2016 Nov; 51(11):1367-74. PubMed ID: 27381376
[TBL] [Abstract][Full Text] [Related]
5. The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis.
Mookerjee RP; Lackner C; Stauber R; Stadlbauer V; Deheragoda M; Aigelsreiter A; Jalan R
J Hepatol; 2011 Nov; 55(5):1103-11. PubMed ID: 21376092
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes in patients with decompensated alcohol-related liver disease, steatohepatitis and Maddrey's discriminant function <32.
Degré D; Stauber RE; Englebert G; Sarocchi F; Verset L; Rainer F; Spindelboeck W; Njimi H; Trépo E; Gustot T; Lackner C; Deltenre P; Moreno C
J Hepatol; 2020 Apr; 72(4):636-642. PubMed ID: 31954208
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis.
Amonker S; Houshmand A; Hinkson A; Rowe I; Parker R
Hepatol Commun; 2023 May; 7(5):. PubMed ID: 37102767
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and natural history of alcoholic liver disease.
Schwartz JM; Reinus JF
Clin Liver Dis; 2012 Nov; 16(4):659-66. PubMed ID: 23101975
[TBL] [Abstract][Full Text] [Related]
9. Fibrosis and alcohol-related liver disease.
Lackner C; Tiniakos D
J Hepatol; 2019 Feb; 70(2):294-304. PubMed ID: 30658730
[TBL] [Abstract][Full Text] [Related]
10. Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.
Shoreibah M; Raff E; Bloomer J; Kakati D; Rasheed K; Kuo YF; Singal AK
Ann Hepatol; 2016; 15(2):183-9. PubMed ID: 26845595
[TBL] [Abstract][Full Text] [Related]
11. Histopathology of Alcohol-Related Liver Diseases.
Roth NC; Qin J
Clin Liver Dis; 2019 Feb; 23(1):11-23. PubMed ID: 30454825
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease.
Haflidadottir S; Jonasson JG; Norland H; Einarsdottir SO; Kleiner DE; Lund SH; Björnsson ES
BMC Gastroenterol; 2014 Sep; 14():166. PubMed ID: 25260964
[TBL] [Abstract][Full Text] [Related]
13. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.
Reeves HL; Burt AD; Wood S; Day CP
J Hepatol; 1996 Nov; 25(5):677-83. PubMed ID: 8938545
[TBL] [Abstract][Full Text] [Related]
14. Mortality of alcohol abusing men prospectively assessed in relation to history of abuse and degree of liver injury.
Orholm M; Sørensen TI; Bentsen K; Høybye G; Eghøje K; Christoffersen P
Liver; 1985 Oct; 5(5):253-60. PubMed ID: 4079665
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis.
Sørensen TI; Orholm M; Bentsen KD; Høybye G; Eghøje K; Christoffersen P
Lancet; 1984 Aug; 2(8397):241-4. PubMed ID: 6146805
[TBL] [Abstract][Full Text] [Related]
16. Clinical syndromes of alcoholic liver disease.
Adachi M; Brenner DA
Dig Dis; 2005; 23(3-4):255-63. PubMed ID: 16508290
[TBL] [Abstract][Full Text] [Related]
17. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Krag A; Karsdal MA; Nielsen MJ; Brockbank S; Cruwys S
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G410-G418. PubMed ID: 31905026
[TBL] [Abstract][Full Text] [Related]
18. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.
Monto A; Alonzo J; Watson JJ; Grunfeld C; Wright TL
Hepatology; 2002 Sep; 36(3):729-36. PubMed ID: 12198667
[TBL] [Abstract][Full Text] [Related]
19. Morphology of alcoholic liver disease.
Lefkowitch JH
Clin Liver Dis; 2005 Feb; 9(1):37-53. PubMed ID: 15763228
[TBL] [Abstract][Full Text] [Related]
20. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.
Lackner C; Spindelboeck W; Haybaeck J; Douschan P; Rainer F; Terracciano L; Haas J; Berghold A; Bataller R; Stauber RE
J Hepatol; 2017 Mar; 66(3):610-618. PubMed ID: 27894795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
